Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles

J Biol Chem. 2017 Nov 3;292(44):18344-18353. doi: 10.1074/jbc.M117.813444. Epub 2017 Sep 15.

Abstract

Apolipoprotein L1 (ApoL1) is a human serum protein conferring resistance to African trypanosomes, and certain ApoL1 variants increase susceptibility to some progressive kidney diseases. ApoL1 has been hypothesized to function like a pore-forming colicin and has been reported to have permeability effects on both intracellular and plasma membranes. Here, to gain insight into how ApoL1 may function in vivo, we used vesicle-based ion permeability, direct membrane association, and intrinsic fluorescence to study the activities of purified recombinant ApoL1. We found that ApoL1 confers chloride-selective permeability to preformed phospholipid vesicles and that this selectivity is strongly pH-sensitive, with maximal activity at pH 5 and little activity above pH 7. When ApoL1 and lipid were allowed to interact at low pH and were then brought to neutral pH, chloride permeability was suppressed, and potassium permeability was activated. Both chloride and potassium permeability linearly correlated with the mass of ApoL1 in the reaction mixture, and both exhibited lipid selectivity, requiring the presence of negatively charged lipids for activity. Potassium, but not chloride, permease activity required the presence of calcium ions in both the association and activation steps. Direct assessment of ApoL1-lipid associations confirmed that ApoL1 stably associates with phospholipid vesicles, requiring low pH and the presence of negatively charged phospholipids for maximal binding. Intrinsic fluorescence of ApoL1 supported the presence of a significant structural transition when ApoL1 is mixed with lipids at low pH. This pH-switchable ion-selective permeability may explain the different effects of ApoL1 reported in intracellular and plasma membrane environments.

Keywords: ApoL1; apolipoprotein L1; chloride channel; membrane transporter reconstitution; nephrology; phospholipid vesicle; potassium channel.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Apolipoprotein L1 / chemistry
  • Apolipoprotein L1 / genetics
  • Apolipoprotein L1 / metabolism*
  • Apolipoprotein L1 / pharmacology
  • Biological Transport
  • Calcium Signaling
  • Cell Membrane / chemistry
  • Cell Membrane / metabolism*
  • Cell Membrane Permeability
  • Cetylpyridinium / chemistry
  • Cetylpyridinium / metabolism*
  • Fluorescence
  • Hydrogen-Ion Concentration
  • Lethal Dose 50
  • Models, Molecular*
  • Phosphatidic Acids / chemistry
  • Phosphatidic Acids / metabolism
  • Phosphatidylcholines / chemistry
  • Phosphatidylcholines / metabolism
  • Phosphatidylethanolamines / chemistry
  • Phosphatidylethanolamines / metabolism
  • Phosphatidylserines / chemistry
  • Phosphatidylserines / metabolism
  • Potassium / chemistry
  • Potassium / metabolism*
  • Protein Stability
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / metabolism
  • Recombinant Fusion Proteins / pharmacology
  • Trypanocidal Agents / chemistry
  • Trypanocidal Agents / metabolism
  • Trypanocidal Agents / pharmacology
  • Trypanosoma brucei brucei / drug effects
  • Trypanosoma brucei brucei / growth & development
  • Unilamellar Liposomes / chemistry
  • Unilamellar Liposomes / metabolism

Substances

  • APOL1 protein, human
  • Apolipoprotein L1
  • Phosphatidic Acids
  • Phosphatidylcholines
  • Phosphatidylethanolamines
  • Phosphatidylserines
  • Recombinant Fusion Proteins
  • Trypanocidal Agents
  • Unilamellar Liposomes
  • Cetylpyridinium
  • Potassium